WAYNE, Pa.--(BUSINESS WIRE)--Jul. 1, 2014--
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical
devices for critical care and surgery, has announced that the Hudson RCI®
ISO-Gard® Mask with ClearAir™ Technology is one of 16 medical
innovations that was showcased in front of thousands of healthcare
providers at the Premier, Inc. 2014 Breakthroughs
Conference and Exhibition in San Antonio.
This Teleflex device was selected by clinicians and other members of
Premier, a leading healthcare improvement company, uniting an alliance
of approximately 3,000 U.S. hospitals and 110,000 other providers.
Selection criteria included the uniqueness of the product, ability to
have an impact on an unmet medical need and potential to improve patient
care.
The ISO-Gard Mask debuted during the conference’s sixth annual Innovation
Celebration. The event recognizes advances in healthcare while
highlighting industry suppliers committed to innovation and improving
patient outcomes.
The ISO-Gard Mask represents our commitment to Post Anesthesia Care Unit
(PACU) managers and nurses to help in the reduction of hazardous waste
anesthetic gas (WAG) exhaled by post-op patients and improve caregiver
safety. This multi-purpose mask scavenges WAG while simultaneously
delivering oxygen to the patient. ClearAir technology provides
unidirectional flow of oxygen through the mask to assure maximum FiO2.
Teleflex estimates that anesthetic gases are used in 20 million
surgeries in the US annually and up to 100 million globally.1
When patients are recovering in the PACU, they may exhale these gases
which are then released into the nurses’ work environment. The
Occupational Safety and Health Administration (OSHA) warns of several
potential health effects from WAG exposure, including nausea, dizziness,
headaches, and fatigue.2
“I am passionate about the opportunity to improve the work environment
of PACU nurses,” said Dr. John Moenning D.D.S., M.S.D. “By implementing
the ISO-Gard Mask we are able to help reduce the possible health risks
from waste anesthetic gases in the PACU and let the nurses know we care
for them as much as the patient.”
“Those who attend and participate in the Innovation Celebration share
Premier’s commitment to providing valuable products to our members that
are safe, high-quality and cost-effective,” said Durral R. Gilbert,
president of supply chain services, Premier. “We believe these
innovations can benefit providers as they work to transform healthcare.”
Any supplier, regardless of whether the company is contracted with
Premier, can be considered for participation in the Innovation
Celebration. Overall, Premier contracts with more than 1,100 suppliers.
About Premier, Inc.
Premier, Inc. is a leading healthcare improvement company, uniting an
alliance of approximately 3,000 U.S. hospitals and 110,000 other
providers to transform healthcare. With integrated data and analytics,
collaboratives, supply chain solutions, and advisory and other services,
Premier enables better care and outcomes at a lower cost. Premier, a
Malcolm Baldrige National Quality Award recipient, plays a critical role
in the rapidly evolving healthcare industry, collaborating with members
to co-develop long-term innovations that reinvent and improve the way
care is delivered to patients nationwide. Headquartered in Charlotte,
N.C., Premier is passionate about transforming American healthcare.
Please visit Premier’s news and investor sites on www.premierinc.com;
as well as Twitter,
Facebook,
LinkedIn,
YouTube,
Instagram,
Foursquare
and Premier’s
blog for more information about the company.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Wayne, PA,
Teleflex employs approximately 11,400 people worldwide and serves
healthcare providers in more than 150 countries. Additional information
about Teleflex can be obtained from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Dr. Moenning is a paid consultant of Teleflex
Teleflex, ClearAir, Hudson RCI and ISO-Gard are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates.
© 2014 Teleflex Incorporated. All rights reserved. MC-000021
Reference:
-
Inpatient Surgery data. Centers for Disease Control and
Prevention. http://www.cdc.gov/nchs/fastats/insurg.htm.
Updated May 16, 2012. Accessed February 13, 2013.
Data
purchased from IMS Institute for Healthcare Informatics on file at
Teleflex.
Weiser TG, Regenbogen SE, Thompson KD, Haynes AB,
Lipsitz SR, Berry WR, Gawande AA. An estimation of the global volume
of surgery: a modelling strategy based on available data. Lancet.
2008 Jul 12;372(9633):139-44. doi: 10.1016/S0140-6736(08)60878-8. http://www.ncbi.nlm.nih.gov/pubmed/18582931
Accessed February 13, 2013.
WHO Guidelines for Safe
Surgery. WHO/IER/PSP/2008.08-1E http://gawande.com/documents/WHOGuidelinesforSafeSurgery.pdf.
Accessed February 13, 2013.
-
Occupational Safety and Health Administration, Anesthetic Gases:
Guidelines for Workplace Exposures. http://www.osha.gov/dts/osta/anestheticgases/index.html.
Accessed February 13, 2013.
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
jake.elguicze@teleflex.com
www.teleflex.com